Africa: WHO Recommends Accelerated Access to New Game-Changing HIV Prevention Drug

[MSF] As the World Health Organization (WHO) recommended long-acting injectable cabotegravir (CAB-LA) for HIV prevention, and the Medicines Patent Pool (MPP) and UK pharmaceutical corporation ViiV Healthcare announced an agreement to open up generic production and supply of CAB-LA in 90 countries, Doctors Without Borders (MSF) called on governments in low- and middle-income countries (LMICs) to urgently include this drug in national HIV guidelines and accelerate its rollout to prevent HIV transmission.
Source: AllAfrica News: HIV-Aids and STDs - Category: Infectious Diseases Source Type: news